Highly sensitive single tube B-lymphoblastic leukemia/lymphoma minimal/measurable residual disease test robust to surface antigen directed therapy.

Qi GaoYing LiuUmut AyparJeeyeon BaikDory LondonoXiaotian SunJingping ZhangYanming ZhangMikhail Roshal

Published in: Cytometry. Part B, Clinical cytometry (2023)

The assay allows for sensitive disease detection of B-ALL MRD independent of CD19 and CD22 expression and allows uniform analysis of samples regardless of anti-CD19 and CD22 therapy.

Keyphrases

nk cells
diffuse large b cell lymphoma
acute myeloid leukemia
mesenchymal stem cells
cell therapy
molecularly imprinted
label free
sensitive detection
loop mediated isothermal amplification
liquid chromatography